Chemed
About: Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Employees: 15,087
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
150% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 5 (+3) [Q3]
15% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 59
2% more funds holding
Funds holding: 510 [Q2] → 519 (+9) [Q3]
5% more call options, than puts
Call options by funds: $2.34M | Put options by funds: $2.22M
4% more capital invested
Capital invested by funds: $8.03B [Q2] → $8.35B (+$325M) [Q3]
4% more repeat investments, than reductions
Existing positions increased: 184 | Existing positions reduced: 177
5.41% less ownership
Funds ownership: 97.72% [Q2] → 92.31% (-5.41%) [Q3]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$633
21%
upside
Avg. target
$633
21%
upside
High target
$633
21%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
RBC Capital Ben Hendrix 25% 1-year accuracy 18 / 71 met price target | 21%upside $633 | Outperform Maintained | 5 Nov 2024 |
Financial journalist opinion
Based on 4 articles about CHE published over the past 30 days
Neutral
Zacks Investment Research
1 week ago
EHC or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Encompass Health (EHC) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Neutral
Business Wire
2 weeks ago
Chemed Corporation to Present at the BofA Securities 2024 Virtual Home Care Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2024 Virtual Home Care Conference on Tuesday, December 10, 2024, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New Y.
Positive
Zacks Investment Research
3 weeks ago
EHC vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Encompass Health (EHC) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Negative
Zacks Investment Research
4 weeks ago
Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth
The ongoing global economic conditions, such as general labor, supply chain and inflationary pressure, along with political and regulatory developments, are escalating expenses for CHE.
Neutral
Seeking Alpha
1 month ago
Chemtrade Logistics Income Fund (CGIFF) Q3 2024 Earnings Call Transcript
Chemtrade Logistics Income Fund (OTC:CGIFF) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ET Company Participants Rohit Bhardwaj - CFO Scott Rook - President and CEO Conference Call Participants Steve Hansen - Raymond James Joel Jackson - BMO Capital Markets Gary Ho - Desjardins Capital Markets Nelson Ng - RBC Capital Markets Zachary Evershed - National Bank Operator Good morning and welcome to the Chemtrade Logistics Income Fund Q3 2024 Conference Call. [Operator Instructions].
Neutral
Business Wire
1 month ago
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payabl.
Neutral
Business Wire
1 month ago
Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2024 Global Healthcare Conference on Tuesday, November 12, 2024, at approximately 2:45 p.m. (ET) at the Terranea Resort in Rancho Palos Verdes, California. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of.
Positive
Zacks Investment Research
1 month ago
AMED or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
Neutral
Seeking Alpha
1 month ago
Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive Officer Mike Witzeman - Chief Financial Officer Nick Westfall - Chairman and Chief Executive Officer, VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good day and thank you for standing by. Welcome to the Chemed Corporation Third Quarter 2024 Earnings Conference Call.
Neutral
Zacks Investment Research
1 month ago
CHE Misses on Q3 Earnings, Lowers '24 EPS View, Stock Up
Chemed's VITAS segment reports impressive revenue growth and margin expansion for the third quarter of 2024.
Charts implemented using Lightweight Charts™